S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Enveric Biosciences Stock Forecast, Price & News

-0.22 (-6.04 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $3.42
50-Day Range N/A
52-Week Range
Now: $3.42
Volume647,257 shs
Average Volume2.41 million shs
Market Capitalization$52.43 million
P/E RatioN/A
Dividend YieldN/A
Enveric Biosciences, Inc., a biotechnology company, engages in developing various cannabinoid medicines to enhance quality of life for cancer patients. It has a pipeline of development programs for radiodermatitis, glioblastoma, and chemotherapy-induced neuropathy. The company is based in Naples, Florida.

Industry, Sector and Symbol

Industry Semiconductors & related devices
Current SymbolNASDAQ:ENVB
Year FoundedN/A



Sales & Book Value

Annual Sales$39.92 million
Book Value$16.90 per share


Net Income$-5,600,000.00


Market Cap$52.43 million
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.13 out of 5 stars

Medical Sector

1790th out of 1,960 stocks

Semiconductors & Related Devices Industry

141st out of 147 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.22 (-6.04 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ENVB News and Ratings via Email

Sign-up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Enveric Biosciences (NASDAQ:ENVB) Frequently Asked Questions

What stocks does MarketBeat like better than Enveric Biosciences?

Wall Street analysts have given Enveric Biosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Enveric Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Enveric Biosciences?

Enveric Biosciences saw a decrease in short interest in January. As of January 29th, there was short interest totaling 90,800 shares, a decrease of 42.4% from the January 14th total of 157,700 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 10.0% of the shares of the company are sold short.
View Enveric Biosciences' Short Interest

When is Enveric Biosciences' next earnings date?

Enveric Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Enveric Biosciences

Who are Enveric Biosciences' key executives?

Enveric Biosciences' management team includes the following people:
  • Mr. John Van Buiten, Chief Financial Officer (Age 33, Pay $102k)
  • Mr. David Ian Johnson, Chairman & CEO (Age 63)
  • Mr. Henoch Cohn, Pres, Sec. & Director
  • Mr. Avani V. Kanubaddi, Chief Operating Officer (Age 48)
  • Dr. Robert G. Wilkins, Chief Medical Officer (Age 66)

Who are some of Enveric Biosciences' key competitors?

What is Enveric Biosciences' stock symbol?

Enveric Biosciences trades on the NASDAQ under the ticker symbol "ENVB."

Who are Enveric Biosciences' major shareholders?

Enveric Biosciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.07%).

Which institutional investors are buying Enveric Biosciences stock?

ENVB stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC.

How do I buy shares of Enveric Biosciences?

Shares of ENVB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Enveric Biosciences' stock price today?

One share of ENVB stock can currently be purchased for approximately $3.42.

How much money does Enveric Biosciences make?

Enveric Biosciences has a market capitalization of $52.43 million and generates $39.92 million in revenue each year.

What is Enveric Biosciences' official website?

The official website for Enveric Biosciences is jaypharma.co.

Where are Enveric Biosciences' headquarters?

Enveric Biosciences is headquartered at 4080 MCGINNIS FERRY ROAD SUITE 1306, ALPHARETTA GA, 30005.

How can I contact Enveric Biosciences?

Enveric Biosciences' mailing address is 4080 MCGINNIS FERRY ROAD SUITE 1306, ALPHARETTA GA, 30005. The company can be reached via phone at 770-935-4152 or via email at [email protected]

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.